Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Old C57BL/6 mice with unsynchronized hair cycles show less melanin in their spleens.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Technique effectively reconstructs large scalp defects with minimal hair loss and visible scarring.

Scalp tissue micrografts can effectively treat hair loss by increasing hair density and thickness.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Hair transplantation can restore underarm hair after surgery, despite challenges.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Controlling Tslp can improve health in AEC syndrome patients.

Hair grafts successfully restored a realistic beard and hid scars, satisfying the patient.

The hole technique is faster and effective for hair transplant site creation.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

A new technique using a multibladed knife makes preparing hair transplant minigrafts faster and more uniform, leading to natural-looking results.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Alopecia areata is an autoimmune disease that targets hair follicles.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

Hair loss improved with treatment and successful transplant.

Vitiligo transplantation surgery is now more efficient, cost-effective, and successful.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

BST2 is highly expressed in certain immune cells in alopecia areata, suggesting a role in the disease.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Mutations in the FOXN1 gene cause severe immune issues but don't affect hair and nails.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Adding collagenase to trypsin improves cell yield and repigmentation in vitiligo treatment.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Thyroid issues can cause alopecia areata.